Charles Schwab Investment Management Inc. Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Charles Schwab Investment Management Inc. boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,101,133 shares of the medical instruments supplier's stock after purchasing an additional 35,360 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.06% of DENTSPLY SIRONA worth $39,880,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of XRAY. Riverview Trust Co purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB lifted its holdings in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,232 shares during the period. UMB Bank n.a. lifted its stake in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares during the period. Venturi Wealth Management LLC raised its position in shares of DENTSPLY SIRONA by 4,893.5% in the third quarter. Venturi Wealth Management LLC now owns 2,297 shares of the medical instruments supplier's stock worth $62,000 after acquiring an additional 2,251 shares during the period. Finally, Brooklyn Investment Group purchased a new position in DENTSPLY SIRONA during the third quarter worth approximately $77,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

DENTSPLY SIRONA Trading Down 0.6 %

XRAY traded down $0.09 during trading hours on Wednesday, reaching $15.65. The company's stock had a trading volume of 1,161,190 shares, compared to its average volume of 2,971,830. The stock has a market cap of $3.11 billion, a PE ratio of -7.56, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a fifty-two week low of $14.78 and a fifty-two week high of $33.72. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business's 50-day moving average is $18.10 and its 200-day moving average is $20.67.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.09%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

Analyst Upgrades and Downgrades

XRAY has been the subject of several recent analyst reports. UBS Group cut their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday, December 3rd. Evercore ISI restated an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Mizuho decreased their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Thursday, March 13th. Finally, Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $23.33.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction on Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. 0.52% of the stock is owned by insiders.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.